These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2895003)

  • 1. Dynorphin A-(1-13) attenuates withdrawal in morphine-dependent rats: effect of route of administration.
    Green PG; Lee NM
    Eur J Pharmacol; 1988 Jan; 145(3):267-72. PubMed ID: 2895003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dynorphin A(1-13) on opiate withdrawal in humans.
    Specker S; Wananukul W; Hatsukami D; Nolin K; Hooke L; Kreek MJ; Pentel PR
    Psychopharmacology (Berl); 1998 Jun; 137(4):326-32. PubMed ID: 9676891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-administration of dynorphin-[1-13] and D-ala2-dynorphin-[1-11] (kappa opioid agonists) in morphine (mu opioid agonist)-dependent rats.
    Khazan N; Young GA; Calligaro D
    Life Sci; 1983; 33 Suppl 1():559-62. PubMed ID: 6319910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynorphin-A-(1-13) antagonizes morphine analgesia in the brain and potentiates morphine analgesia in the spinal cord.
    Ren MF; Lu CH; Han JS
    Peptides; 1985; 6(6):1015-20. PubMed ID: 2871545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of morphine-induced EEG and behavioral effects by dynorphin A-(1-13) in non-tolerant and morphine-tolerant rats.
    Hong O; Young GA; Khazan N
    Neuropharmacology; 1988 Aug; 27(8):807-12. PubMed ID: 2905786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression by dynorphin A and [des-Tyr1]dynorphin A peptides of the expression of opiate withdrawal and tolerance in morphine-dependent mice.
    Takemori AE; Loh HH; Lee NM
    J Pharmacol Exp Ther; 1993 Jul; 266(1):121-4. PubMed ID: 8101214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecally administered dynorphin-(1-17) modulates morphine-induced antinociception differently in morphine-naive and morphine-tolerant rats.
    Schmauss C; Herz A
    Eur J Pharmacol; 1987 Mar; 135(3):429-31. PubMed ID: 2884124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of acute morphine tolerance by corticotropin-releasing factor and dynorphin A in the mouse spinal cord.
    Song SH; Takemori AE
    Life Sci; 1992; 51(2):107-11. PubMed ID: 1352026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression by dynorphin A-(1-13) of the expression of opiate withdrawal and tolerance in mice.
    Takemori AE; Loh HH; Lee NM
    Eur J Pharmacol; 1992 Oct; 221(2-3):223-6. PubMed ID: 1358653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulators of pain in the spinal cord.
    Jen MF; Lu CH; Huang L; Han JS
    NIDA Res Monogr; 1986; 75():457-60. PubMed ID: 2893278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of morphine tolerance dependence and abstinence on immunoreactive dynorphin (1-13) levels in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of the rat.
    Rattan AK; Koo KL; Tejwani GA; Bhargava HN
    Brain Res; 1992 Jul; 584(1-2):207-12. PubMed ID: 1355391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of morphine withdrawal by electroacupuncture in rats: dynorphin and kappa-opioid receptor implicated.
    Wu LZ; Cui CL; Tian JB; Ji D; Han JS
    Brain Res; 1999 Dec; 851(1-2):290-6. PubMed ID: 10642860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of morphine treatment and morphine withdrawal on the dynorphin and enkephalin systems in Sprague-Dawley rats.
    Nylander I; Vlaskovska M; Terenius L
    Psychopharmacology (Berl); 1995 Apr; 118(4):391-400. PubMed ID: 7568625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynorphin A (2-17) attenuates the unconditioned but not the conditioned effects of opiate withdrawal in the rat.
    Shippenberg TS; Funada M; Schutz CG
    Psychopharmacology (Berl); 2000 Sep; 151(4):351-8. PubMed ID: 11026742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ICV administration of CRF blocker (CRF9-41 delta helical) reduces morphine withdrawal in rats.
    Brugger S; Sánchez R; Brugger AJ; Martinez JA
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Jul; 22(5):775-85. PubMed ID: 9723119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressive effects by cysteine protease inhibitors on naloxone-precipitated withdrawal jumping in morphine-dependent mice.
    Tan-No K; Sato T; Shimoda M; Nakagawasai O; Niijima F; Kawamura S; Furuta S; Sato T; Satoh S; Silberring J; Terenius L; Tadano T
    Neuropeptides; 2010 Jun; 44(3):279-83. PubMed ID: 20189644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic responses of conscious rats following intrathecal injections of prodynorphin-derived opioids: independence of action of intrathecal arginine vasopressin.
    Thornhill JA; Pittman QJ
    Can J Physiol Pharmacol; 1990 Feb; 68(2):174-82. PubMed ID: 1968777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analgesic effects of dynorphin-A and morphine in mice.
    Nakazawa T; Ikeda M; Kaneko T; Yamatsu K
    Peptides; 1985; 6(1):75-8. PubMed ID: 2859574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The kappa-opioid receptor antagonist, nor-binaltorphimine (nor-BNI), decreases morphine withdrawal and the consequent conditioned place aversion in rats.
    Kelsey JE; Verhaak AM; Schierberl KC
    Behav Brain Res; 2015 Apr; 283():16-21. PubMed ID: 25591478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substance P-(1-7), a substance P metabolite, inhibits withdrawal jumping in morphine-dependent mice.
    Kreeger JS; Larson AA
    Eur J Pharmacol; 1993 Jul; 238(1):111-5. PubMed ID: 7691618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.